$58.020
-0.337 (-0.58%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de ARWR por análisis de gráficos similares
Alphio's ARWR stock price prediction model matches the current Arrowhead Pharmaceuticals, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $57.81 (-0.36%). The 1-week path is $58.04 (+0.04%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Arrowhead Pharmaceuticals, Inc.?
Arrowhead Pharmaceuticals Inc is currently a hold. The stock is priced at $55.90, significantly below the analyst price targets of $74 from Goldman Sachs and $108 from Citi, indicating potential upside. However, the RSI is at a very low 17.125, suggesting the stock is oversold, which could lead to a rebound. The company has shown promising early trial results for its Alzheimer's drug, ARO-MAPT, with a 73% reduction in tau protein levels, which could drive future growth. However, the risk remains high as the stock has a forward P/E of 111.11 and has seen a 10.92% decline over the past five days, indicating volatility and uncertainty in the market.
ARWR cerró en $58.02 el Friday, tras bajar -0.58%
Arrowhead Pharmaceuticals, Inc. (ARWR) last closed at $58.02, losing -0.58%. These facts feed the 1-day and 1-week ARWR price prediction above.
Factores de la previsión
Los factores de la previsión de Arrowhead Pharmaceuticals, Inc. (ARWR) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de ARWR, ordenadas por similitud.
Análisis de estacionalidad de ARWR
Historically the probability of a positive October return for ARWR is 36.51%. January offers the highest probability of a positive month at 59.02%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de ARWR
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Oct 2026 | $15.27 | $16.90 | $20.94 | -70.88% |
| Nov 2026 | $16.44 | $18.99 | $20.96 | -67.27% |
| Dec 2026 | $14.63 | $18.75 | $20.14 | -67.68% |
En 2026, se proyecta que Arrowhead Pharmaceuticals, Inc. (ARWR) oscile entre $14.63 y $20.96.
Previsión mensual de Arrowhead Pharmaceuticals, Inc. para 2026
En Oct de 2026, se proyecta que Arrowhead Pharmaceuticals, Inc. promedie $16.90, con un mínimo de $15.27 y un máximo de $20.94.
En Nov de 2026, se proyecta que Arrowhead Pharmaceuticals, Inc. promedie $18.99, con un mínimo de $16.44 y un máximo de $20.96.
En Dec de 2026, se proyecta que Arrowhead Pharmaceuticals, Inc. promedie $18.75, con un mínimo de $14.63 y un máximo de $20.14.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.